MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Doximity, Inc. Class A Common Stock (NY:DOCS)

24.53 -0.57 (-2.27%)
Official Closing Price Updated: 4:10 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Doximity, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
News headline image
uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? 
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
ZoomInfo, SentinelOne, Toast, Doximity, and American Express Global Business Travel Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after Nvidia CEO Jensen Huang dismissed fears that artificial intelligence would cannibalize the enterprise software sector. 
Via StockStory
Topics Artificial Intelligence
News headline image
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Doximity Inc. (NYSE:DOCS) Fits the "Affordable Growth" Investment Strategy ↗
Via Chartmill
Doximity Inc-Class A (NYSE:DOCS) Plummets on Weak Revenue Outlook Despite Q3 Beat ↗
Via Chartmill
Doximity Inc-Class A (NYSE:DOCS) Passes the "Caviar Cruise" Quality Investing Screen ↗
Via Chartmill
News headline image
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? 
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight. ↗
Investors are selling off software stocks, creating buying opportunities for smart investors. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2 Cash-Producing Stocks to Target This Week and 1 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
News headline image
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? 
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Turn Down
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
News headline image
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights 
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
5 Revealing Analyst Questions From Doximity’s Q4 Earnings Call
Doximity’s fourth quarter results for 2025 were met with a sharp negative market reaction, as management cited a combination of delayed pharmaceutical industry budgets and a notable increase in... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
William Blair Dumps $21 Million of Healthcare Platform Doximity Stock ↗
Doximity connects U.S. medical professionals through a cloud-based digital platform serving healthcare and pharmaceutical clients. 
Via The Motley Fool
News headline image
2 Oversold Stocks Primed to Rebound and 1 We Turn Down
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
Topics Artificial Intelligence
News headline image
Doximity (DOCS) Stock Plummets 17% on Weak Guidance and AI Cost Surges
The digital healthcare landscape faced a harsh reality check on February 6, 2026, as shares of Doximity, Inc. (NYSE: DOCS) plummeted 17% in early trading. Despite reporting fiscal third-quarter results... 
Via MarketMinute
Topics Artificial Intelligence Initial Public Offering
News headline image
Why Doximity Stock Plummeted Today ↗
Doximity's stock is sinking on conservative guidance, but its long-term investment thesis remains intact. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Why Did DOCS Stock Plunge 35% In Pre-Market Today? ↗
Multiple brokerages cut their price target on the stock after Doximity reported a fall in third-quarter earnings and a soft fourth-quarter revenue outlook. 
Via Stocktwits
News headline image
Doximity (DOCS) Q3 2026 Earnings Call Transcript ↗
Doximity (DOCS) Q3 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
Get insights into the top gainers and losers of Friday's pre-market session. ↗
Via Chartmill
News headline image
DOCS Q4 Deep Dive: AI Momentum Overshadowed by Pharma Budget Delays and Cautious Guidance
Medical professional network Doximity (NYSE:DOCS) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 9.8% year on year to $185.1 million. On the other hand, next... 
Via StockStory
Topics Artificial Intelligence
News headline image
Doximity Stock Is Collapsing After Hours: Here&#39;s Why ↗
Doximity Inc (NYSE:DOCS) reports third-quarter results for fiscal 2026 after the market close on Thursday, and shares are tumbling. 
Via Benzinga
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Doximity (NYSE:DOCS) Beats Q4 CY2025 Sales Expectations But Stock Drops 32.5%
Medical professional network Doximity (NYSE:DOCS) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.8% year on year to $185.1 million. On the other hand, next... 
Via StockStory
News headline image
Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fifth Consecutive Year
From Doximity
Via Business Wire
News headline image
Doximity Announces Fiscal 2026 Third Quarter Financial Results
From Doximity
Via Business Wire
News headline image
monday.com, Braze, Doximity, Freshworks, and BlackLine Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the "AI replacement" narrative reached a fever pitch following the release of new models from Anthropic and OpenAI. 
Via StockStory
Topics Artificial Intelligence
News headline image
Can Waystar Still Stand Up to Rising Competition? ↗
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story